Through Kaplan–Meier and log‐rank test analyses in 122 NSCLC patients, high HMGB1 expression was correlated with worse overall survival time (P < 0.05, Fig. 1D). This evidence concerns the gene HMGB1 and non-small cell lung carcinoma.